| Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study E Lalonde, AS Ishkanian, J Sykes, M Fraser, H Ross-Adams, N Erho, ... The lancet oncology 15 (13), 1521-1532, 2014 | 379 | 2014 |
| Integration of copy number and transcriptomics provides risk stratification in prostate cancer: a discovery and validation cohort study H Ross-Adams, AD Lamb, MJ Dunning, S Halim, J Lindberg, CM Massie, ... EBioMedicine 2 (9), 1133-1144, 2015 | 287 | 2015 |
| Integration of copy number and transcriptomics provides risk stratification in prostate cancer: a discovery and validation cohort study. EBioMedicine. 2015; 2: 1133–44 H Ross-Adams, AD Lamb, MJ Dunning, S Halim, J Lindberg, CM Massie, ... | 287* | 2015 |
| Gene regulatory mechanisms underpinning prostate cancer susceptibility T Whitington, P Gao, W Song, H Ross-Adams, AD Lamb, Y Yang, I Svezia, ... Nature genetics 48 (4), 387-397, 2016 | 124 | 2016 |
| Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression Z Kote-Jarai, EJ Saunders, DA Leongamornlert, M Tymrakiewicz, ... Human molecular genetics 22 (12), 2520-2528, 2013 | 123 | 2013 |
| 5-hydroxymethylcytosine marks promoters in colon that resist DNA hypermethylation in cancer S Uribe-Lewis, R Stark, T Carroll, MJ Dunning, M Bachman, Y Ito, L Stojic, ... Genome biology 16, 1-15, 2015 | 84 | 2015 |
| Estimating malaria parasitaemia from blood smear images S Halim, TR Bretschneider, Y Li, PR Preiser, C Kuss 2006 9th international conference on control, automation, robotics and …, 2006 | 83 | 2006 |
| FGFR2 risk SNPs confer breast cancer risk by augmenting oestrogen responsiveness TM Campbell, MAA Castro, I de Santiago, MNC Fletcher, S Halim, ... Carcinogenesis 37 (8), 741-750, 2016 | 54 | 2016 |
| Translating a prognostic DNA genomic classifier into the clinic: retrospective validation in 563 localized prostate tumors E Lalonde, R Alkallas, MLK Chua, M Fraser, S Haider, A Meng, J Zheng, ... European urology 72 (1), 22-31, 2017 | 52 | 2017 |
| HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer H Ross-Adams, S Ball, K Lawrenson, S Halim, R Russell, C Wells, ... Oncotarget 7 (46), 74734, 2016 | 45 | 2016 |
| Analysis of cell proliferation and tissue remodelling uncovers a KLF4 activity score associated with poor prognosis in colorectal cancer S Halim, EK Markert, A Vazquez British Journal of Cancer 119 (7), 855-863, 2018 | 15 | 2018 |
| Pan-cancer analysis of tissue and single-cell HIF-pathway activation using a conserved gene signature O Lombardi, R Li, S Halim, H Choudhry, PJ Ratcliffe, DR Mole Cell Reports 41 (7), 111652, 2022 | 13 | 2022 |
| Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study. EBioMedicine 2, 1133–1144 H Ross-Adams, AD Lamb, MJ Dunning, S Halim, J Lindberg, CM Massie, ... | 12 | 2015 |
| Multi-level interaction between HIF and AHR transcriptional pathways in kidney carcinoma VN Lafleur, S Halim, H Choudhry, PJ Ratcliffe, DR Mole Life Science Alliance 6 (4), 2023 | 3 | 2023 |
| Corrigendum to “Integration of Copy Number and Transcriptomics Provides Risk Stratification in Prostate Cancer: A Discovery and Validation Cohort Study”[EBioMedicine 2 (9)(2015 … H Ross-Adams, AD Lamb, MJ Dunning, S Halim, J Lindberg, CM Massie, ... EBioMedicine 17, 238, 2017 | 1 | 2017 |
| Pan-cancer analysis of HIF pathways defines a robust molecular signature that reflects tissue and cellular hypoxia in bulk and single-cell RNA-seq analyses O Lombardi, R Li, S Halim, PJ Ratcliffe, DR Mole Cancer Research 82 (12_Supplement), 119-119, 2022 | | 2022 |
| Bi-directional crosstalk between the HIF and AHR transcription factors in clear cell kidney cancer VN Lafleur, S Halim, PJ Ratcliffe, DR Mole Cancer Research 82 (12_Supplement), 677-677, 2022 | | 2022 |
| Pan-cancer analysis of the HIF-transcriptional pathway and its association with genetic susceptibility to cancer DR Mole, V Schmid, O Lombardi, S Halim, VN Lafleur, R Li, R Salama, ... Cancer Research 80 (16_Supplement), 3436-3436, 2020 | | 2020 |
| Heterogeneity analyses using genomics and the tumour microenvironment to predict prostate cancer recurrence E Lalonde, AS Ishkanian, J Sykes, M Fraser, H Ross-Adams, N Erho, ... GENOME 57 (7), 380-380, 2014 | | 2014 |
| Tumour genomic and microenvironmental heterogeneity as integrated predictors for prostate cancer recurrence: a retrospective study E Lalonde, AS Ishkanian, J Sykes, M Fraser, H Ross-Adams, N Erho, ... The Lancet Oncology 15 (13), 1521-1532, 2014 | | 2014 |
